STADA Arzneimittel AG

Explore STADA

As a pharmaceutical and healthcare company, STADA takes responsibility for the safety of its products and the well-being of patients. In our 2024 Sustainability Report, we outline our approach to sustainability, share our ESG commitments, and report on the progress we have made.

World Parkinson’s Day

Raising awareness for the world’s second most common neurodegenerative disease. By 2050, 25 million people could be affected. Parkinson’s goes beyond movement – it impacts everyday life and mental health. At STADA, we stand for progress, solidarity and hope.

Your opportunity for success with STADA

We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.

Careers at STADA

Growth mindset: Our people are our ambassadors

STADA Group is delivering! We are more than just a team – we have an enterprise-wide growth mindset organization.

Peter Goldschmidt, CEO, STADA

STADA Voices

Miguel Pagan Fernandez

Latest news

07/03/2025

STADA’s growth journey continues in 2024

09/01/2025

STADA sets course for the future- experienced healthcare manager Andreas Fibig to become Chairman of the Board

04/12/2024

STADA welcomes Ingo Schachel as Head of Investor Relations

31/10/2024

New STADA facility in Romania for sustainable medicines supply in Europe

10/10/2024

EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar

28/08/2024

STADA continues strong growth journey in the first half of 2024

26/07/2024

European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine

24/06/2024

STADA Health Report 2024: Satisfaction with healthcare systems continues to decline

Read our news

Consumer Healthcare products

STADA is the fourth-largest consumer healthcare company in Europe and markets products internationally in all relevant healthcare categories. The most significant drivers are the Local Hero Brands, strong regional brands and newly acquired products that successfully complement the existing product range.

View our brands

Improving access to life-changing treatments for patients worldwide

Specialty Pharmaceuticals are medicines, that give patients access to innovative treatment options, especially for chronic, severe or rare diseases.

STADA’s Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions.

Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People’s Health as a Trusted Partner”.

Specialty Pharmaceuticals

Affordable generics have been the backbone of STADA since 1895

As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales.

Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure.

Generics

Our purpose is ‘Caring for People’s Health as a Trusted Partner’

At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business –

and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty.

Our purpose